Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2026-02-23 00:00:00 ET · period of report 2026-02-19 · accession 0000875320-26-000102 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-23 | 2026-02-19 | VRTX | Sachdev Amit | EVP Chief Patient, Ext Af Off | S - Sale+OE | $468.83 | -58.6K | 63.2K | -48% | -$27.48M |
| DM | 2026-02-23 | 2026-02-19 | VRTX | Sachdev Amit | EVP Chief Patient, Ext Af Off | M - OptEx | $172.06 | +48.5K | 117.5K | +70% | +$8.35M |
| DM | 2026-02-23 | 2026-02-19 | VRTX | Sachdev Amit | EVP Chief Patient, Ext Af Off | M - OptEx | $0.00 | -48.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-19 | S | D | 2,730 | $465.05 | 113,897 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $465.05 (range $464.48 to $465.46). (F3) Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2026-02-19 | S | D | 4,237 | $471.43 | 58,934 | D | — | — | (F3) Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F10) Open market sales reported on this line occurred at a weighted average price of $471.43 (range $471.10 to $472.03). |
| 3 | Common | Common Stock | 2026-02-19 | M | A | 23,479 | $155.57 | 92,521 | D | — | — | |
| 4 | Common | Common Stock | 2026-02-19 | M | A | 25,026 | $187.53 | 117,547 | D | — | — | |
| 5 | Common | Common Stock | 2026-02-19 | S | D | 920 | $463.91 | 116,627 | D | — | — | (F3) Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F2) Open market sales reported on this line occurred at a weighted average price of $463.91 (range $463.44 to $464.28). |
| 6 | Common | Common Stock | 2026-02-19 | S | D | 1,848 | $465.80 | 112,049 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $465.80 (range $465.54 to $466.49). (F3) Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2026-02-19 | S | D | 10,263 | $467.75 | 101,786 | D | — | — | (F3) Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F6) Open market sales reported on this line occurred at a weighted average price of $467.75 (range $467.09 to $468.05). |
| 8 | Common | Common Stock | 2026-02-19 | S | D | 19,662 | $468.57 | 82,124 | D | — | — | (F7) Open market sales reported on this line occurred at a weighted average price of $468.57 (range $468.10 to $469.09). (F3) Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 9 | Common | Common Stock | 2026-02-19 | S | D | 7,241 | $469.61 | 74,883 | D | — | — | (F3) Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F8) Open market sales reported on this line occurred at a weighted average price of $469.61 (range $469.10 to $470.05). |
| 10 | Common | Common Stock | 2026-02-19 | S | D | 11,712 | $470.54 | 63,171 | D | — | — | (F9) Open market sales reported on this line occurred at a weighted average price of $470.54 (range $470.10 to $471.08). (F3) Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 11 | Derivative | Stock Option (Right to Buy) | 2026-02-19 | M | D | 25,026 | $0.00 | 0 | D | $187.53 · — to 2029-02-05 | 25,026 Common Stock | (F11) Fully vested. |
| 12 | Derivative | Stock Option (Right to Buy) | 2026-02-19 | M | D | 23,479 | $0.00 | 0 | D | $155.57 · — to 2028-02-05 | 23,479 Common Stock | (F11) Fully vested. |